EJMK Ventures LLC acquired a new stake in shares of UBS Group AG (NYSE:UBS – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,398 shares of the bank’s stock, valued at approximately $528,000.
Several other hedge funds have also added to or reduced their stakes in UBS. Vanguard Group Inc. grew its holdings in shares of UBS Group by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 139,105,725 shares of the bank’s stock valued at $6,423,207,000 after buying an additional 1,758,287 shares during the last quarter. Norges Bank purchased a new stake in shares of UBS Group during the fourth quarter valued at $4,889,413,000. Fisher Asset Management LLC boosted its position in shares of UBS Group by 4.8% during the fourth quarter. Fisher Asset Management LLC now owns 64,107,264 shares of the bank’s stock valued at $2,968,807,000 after buying an additional 2,938,827 shares during the last quarter. Wellington Management Group LLP increased its holdings in UBS Group by 254.9% in the 3rd quarter. Wellington Management Group LLP now owns 63,671,310 shares of the bank’s stock worth $2,601,589,000 after buying an additional 45,731,061 shares in the last quarter. Finally, Capital World Investors raised its position in UBS Group by 1.0% in the 3rd quarter. Capital World Investors now owns 37,343,504 shares of the bank’s stock worth $1,525,163,000 after buying an additional 386,264 shares during the last quarter.
UBS Group Stock Performance
UBS opened at $50.80 on Friday. The firm has a market cap of $158.70 billion, a P/E ratio of 18.21, a PEG ratio of 0.85 and a beta of 1.19. UBS Group AG has a 1-year low of $30.36 and a 1-year high of $51.12. The company has a 50 day simple moving average of $45.73 and a two-hundred day simple moving average of $43.88. The company has a debt-to-equity ratio of 1.23, a current ratio of 0.85 and a quick ratio of 1.19.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on UBS shares. Barclays upgraded shares of UBS Group from an “underweight” rating to an “equal weight” rating in a research note on Monday, April 20th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of UBS Group in a research note on Wednesday, May 13th. Royal Bank Of Canada reissued an “outperform” rating on shares of UBS Group in a research report on Thursday, May 7th. Weiss Ratings lowered shares of UBS Group from a “buy (b+)” rating to a “buy (b)” rating in a research report on Monday, May 4th. Finally, Citigroup reiterated a “neutral” rating on shares of UBS Group in a research note on Thursday, April 23rd. Four equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $60.30.
Check Out Our Latest Stock Analysis on UBS
About UBS Group
UBS Group AG is a Swiss multinational financial services firm that provides a broad range of banking and capital markets services to private, institutional and corporate clients. Headquartered in Zurich, UBS operates as a universal bank with a primary focus on wealth management, asset management, investment banking and retail and commercial banking in Switzerland. The firm serves high-net-worth and ultra-high-net-worth individuals, pension funds, corporations and institutional investors through a global network of offices.
Key business activities include global wealth management—offering financial planning, investment advisory, discretionary portfolio management and custody services—alongside asset management products for institutional and retail investors.
Read More
- Five stocks we like better than UBS Group
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for UBS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS Group and related companies with MarketBeat.com's FREE daily email newsletter.
